| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, M Elshaer, C Abbafati, H Abbastabar, ... The Lancet, 2024 | 552 | 2024 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet, 2024 | 517 | 2024 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, M Elshaer, AY Aravkin, P Zheng, KH Abate, YH Abate, ... The Lancet 403 (10440), 2162-2203, 2024 | 514 | 2024 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology, 2024 | 484 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, H Kyu, A Aali, C Abbafati, J Abbas, M Elshaer, ... The Lancet, 2024 | 319 | 2024 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, M Elshaer, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 225 | 2024 |
| Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, ... The Lancet, 2024 | 95 | 2024 |
| The mycobiome: cancer pathogenesis, diagnosis, and therapy A Gamal, M Elshaer, M Alabdely, A Kadry, TS McCormick, M Ghannoum Cancers 14 (12), 2875, 2022 | 25 | 2022 |
| The burden of diseases, injuries, and risk factors by state in the USA, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 GBD 2021 US Burden of Disease Collaborators The Lancet 404 (10469), 2314-2340, 2024 | 16 | 2024 |
| Carbapenem resistance in Gram-negative bacteria: a hospital-based study in Egypt AA Elrahem, N El-Mashad, M Elshaer, H Ramadan, G Damiani, M Bahgat, ... Medicina 59 (2), 285, 2023 | 11 | 2023 |
| Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021 SB Sirota, MC Doxey, RMV Dominguez, M Elshaer, A Vongpradith, ... The Lancet Infectious Diseases, 2024 | 10 | 2024 |
| Role of gut microbiome in neoadjuvant chemotherapy response in urothelial carcinoma: a multi-institutional prospective cohort evaluation L Bukavina, R Ginwala, M Eltoukhi, M Sindhani, M Prunty, DM Geynisman, ... Cancer Research Communications 4 (6), 1505-1516, 2024 | 9 | 2024 |
| Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021 H Comfort, TA McHugh, M Elshaer, A Harris, EA May, KR Paulson, ... The Lancet, 2024 | 7 | 2024 |
| Type III Secretion System (Exoenzymes) as a Virulence Determinant in Pseudomonas aeruginosa Isolated from Burn Patients in Mansoura University Hospitals, Egypt R Mokhtar Elnagar, M Elshaer, O Osama Shouman, S Sabry El-Kazzaz مجله میکروب شناسی پزشکی ایران, 3-3, 2022 | 7* | 2022 |
| Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic … HH Kyu, M Elshaer, RMV Dominguez, J Ma, SB Albertson, A Novotney, ... The Lancet Infectious Diseases, 2024 | 5 | 2024 |
| Silver nanoparticles display inhibitory effect against drug-resistant pathogenic Candida isolates from different clinical specimens RM Elnagar, M Elshaer, A El-Raouf, A Mona Egyptian Journal of Botany 63 (1), 305-314, 2023 | 5 | 2023 |
| Antifungal Activity of Efinaconazole Compared with Fluconazole, Itraconazole, and Terbinafine Against Terbinafine-and Itraconazole-Resistant/Susceptible Clinical Isolates of … A Gamal, M Elshaer, L Long, TS McCormick, B Elewski, MA Ghannoum Journal of the American Podiatric Medical Association 114 (5), 2024 | 4 | 2024 |
| Serratia plymuthica: a true pathogen in transplant patients MY Elshaer PAMJ - Clinical Medicine 1 (57), 2019 | 4 | 2019 |
| Nosocomial yeast infections among cancer patients in Egypt: species distribution and antifungal susceptibility profile NBED El-Mashad, AMA Aal, AM Elewa, MYS Elshaer Jundishapur Journal of Microbiology 12 (2), 1-7, 2019 | 4 | 2019 |
| Adherence and effectiveness of HBV vaccination among healthcare workers in Egypt M Elshaer, E Elsayed, AH El-Gilany, N El-Mashad, M Mansour Indian Journal of Occupational and Environmental Medicine 25 (2), 91-95, 2021 | 3 | 2021 |
Mahmoud GhannoumCase Western Reserve Universitycase.edu üzerinde doğrulanmış e-posta adresine sahip
